HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

Research To Practice | Oncology Videos · Mar 27, 2025 · 1h 3m

Featuring an interview with Dr Sara A Hurvitz, including the following topics:

Role of endocrine therapy in the management of HER2-positive breast cancer; implications of the Phase III PATINA study (0:00)

Case: A woman in her mid 60s with node-negative, HR-positive, HER2-negative localized breast cancer and a Recurrence Score® of 28 (8:38)

Available data guiding the selection of an adjuvant CDK4/6 inhibitor (12:49)

Selection of a CDK4/6 inhibitor in the metastatic setting (23:16)

Available therapies for patients with HR-positive metastatic breast cancer (mBC) and PIK3CA mutations…